<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Geisler Lowry | Activity</title>
	<link>https://www.catswannabecats.com/members/icecloudy1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/icecloudy1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Geisler Lowry.</description>
	<lastBuildDate>Tue, 16 Jun 2026 10:24:03 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b73f6424aa7134acc8255108361b8ec9</guid>
				<title>Geisler Lowry posted an update: The UK's National Institute for Health and Care Excellence [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/26440/</link>
				<pubDate>Tue, 10 Jun 2025 10:48:31 -0400</pubDate>

									<content:encoded><![CDATA[<p>The UK&#8217;s National Institute for Health and Care Excellence (NICE) recently launched a consultation on the methods it uses to evaluate new health technologies, and has highlighted the issue of how &#8216;modifiers&#8217;, including equity weights, should be incorporated into its processes. <a href="https://www.selleckchem.com/peptide/avexitide.html" rel="nofollow ugc">selleck inhibitor</a> The practice of applying equity weights to specific&hellip;<span class="activity-read-more" id="activity-read-more-26440"><a href="https://www.catswannabecats.com/activity/p/26440/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e053877c7695d29bfd10b34f4f318d67</guid>
				<title>Geisler Lowry posted an update: 284 [1.893-11.413], together with increased neutrophil count [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23797/</link>
				<pubDate>Sun, 08 Jun 2025 10:36:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>284 , together with increased neutrophil count (OR = 1.029 ) and WHO disease severity class (OR = 7.632 ). AUROC analysis showed a good discriminative performance of MR-proADM (AUROC 0.849 ; p  less then  0.0001). The optimal value of MR-proADM to discriminate combined event of death or IOT is 0.895 nmol/l, with a sensitivity of 0.857  and a speci&hellip;<span class="activity-read-more" id="activity-read-more-23797"><a href="https://www.catswannabecats.com/activity/p/23797/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a2fad5ae8ad35f1e3605af81c380d812</guid>
				<title>Geisler Lowry posted an update: Our results suggest that, at therapeutically relevant [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22212/</link>
				<pubDate>Sat, 07 Jun 2025 10:50:19 -0400</pubDate>

									<content:encoded><![CDATA[<p>Our results suggest that, at therapeutically relevant concentrations, the cytotoxicity of the platinum compound dominated over that of the PARP inhibitor and the PI3K inhibitor, even though a regression-based model could have indicated an overall synergy at lower and/or higher concentrations.Increasing need in society to provide collaborative and&hellip;<span class="activity-read-more" id="activity-read-more-22212"><a href="https://www.catswannabecats.com/activity/p/22212/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ecbc0ff3d09c29d921454ceb5795b1e7</guid>
				<title>Geisler Lowry posted an update: Cholesterotic fibrous histiocytoma is a particularly rare [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9100/</link>
				<pubDate>Sat, 31 May 2025 22:09:43 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cholesterotic fibrous histiocytoma is a particularly rare variant of dermatofibroma that is distinguished histopathologically by the presence of prominent cholesterol deposits within the lesion. We report the case of a 54-year-old male with poorly controlled hyperlipidemia who presented with a firm violaceous papule on the right shin, diagnosed as&hellip;<span class="activity-read-more" id="activity-read-more-9100"><a href="https://www.catswannabecats.com/activity/p/9100/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f18e67cdad80230200c1ad2b18bc68bb</guid>
				<title>Geisler Lowry became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8982/</link>
				<pubDate>Sat, 31 May 2025 21:59:23 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>